诺华公司Novartis AG (NVS) 2005年年度报告「NYSE」.pdf

1、CARING AND CURINGANNUAL REPORT 2005CENTRE HOSPITALIER UNIVERSITAIRE(CTU);TOULOUSE,FRANCE1GROUP REVIEWOUR MISSIONCONTENTSNOVARTIS GROUP BUSINESS REVIEWGROUP REVIEW2FINANCIAL HIGHLIGHTS3NEWS5LETTER FROM DANIEL VASELLAOPERATIONAL REVIEW12BUSINESS OVERVIEW:PHARMACEUTICALSSANDOZCONSUMER HEALTH22BUSINESS

2、STORIESCORPORATE CITIZENSHIP48INTRODUCTION57COMMITMENT TO PATIENTS62COMMITMENT TO OUR PEOPLE67COMMITMENT TO HEALTH,SAFETY AND ENVIRONMENT74COMMITMENT TO ETHICALBUSINESS CONDUCTCORPORATE GOVERNANCE79COMMITMENT TO CORPORATEGOVERNANCE98BOARD OF DIRECTORS104EXECUTIVE COMMITTEE108BUSINESS UNIT HEADSNOVAR

3、TIS GROUP FINANCIAL REPORT111CONTENTS114OPERATING&FINANCIAL REVIEW134EQUITY STRATEGY136NOVARTIS GROUP CONSOLIDATEDFINANCIAL STATEMENTS198NOVARTIS AG FINANCIALSTATEMENTS204KEY DATES 2006205CONTACT ADDRESSESWe want to discover,develop and success-fully market innovative products to cure diseases,to ea

4、se suffering and to enhancethe quality of life.We also want to provide a shareholderreturn that reflects outstanding performanceand to adequately reward those who investideas and work in our company.FRONT COVER:NURSE AND CHILD;JINKA HOSPITAL;JINKA,ETHIOPIANET SALES,OPERATING INCOME AND NET INCOME(in

5、 USD millions)35000300002500020000150001000050000GROUP REVIEWFINANCIAL HIGHLIGHTS2NOVARTIS GROUP BUSINESS REVIEW 2005 KEY FIGURES(in USD millions unless indicated otherwise)200520041Net sales32 21228 247Operating income6 9056 289Return on sales(%)21.422.3Net income6 1415 601Research and development4

6、 8464 077Research and developmentas%of net sales15.014.4Free cash flow4 6733 301Number of employees at year end90 92481 3921Pro forma except net sales and employeesFINANCIAL HIGHLIGHTSNet sales Operating income Net income 1Not adjusted for new IFRS accounting rules2Pro formaSHARE INFORMATION20052004